NPCE - NASDAQ
NeuroPace, Inc.
$15.88
-2.5%NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
At a Glance
Live SnapshotNeuroPace, Inc. Management Team
Mr. Joel D. Becker
Chief Executive Officer, President & Director
Compensation
$920,381
Ms. Rebecca L. Kuhn
Chief Financial Officer and Vice President of Finance & Administration
Compensation
$591,917
Dr. Martha J. Morrell M.D.
Chief Medical Officer
Compensation
$668,162
Mr. Dylan St. John
Chief of Operations & Development
Ms. Leah Akin
General Counsel & Corporate Secretary
Ms. Amy Treadwell
Vice President of Human Resources
Ms. Katie Keller
Vice President of Marketing
Ms. Kelley Nicholas
Vice President of Sales
NeuroPace, Inc. Insider Positioning
During the last 12 months, insiders have purchased $977K and sold $451K worth of NPCE shares, resulting in $526K of net buying activity.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
0
0.00
25.0K
399.25K
-399K
-$399K
6-9 Months
6.2K
61.85K
0
0.00
+62K
+$62K
9-12 Months
88.0K
915.56K
5.9K
52.11K
+863K
+$863K
Top Buyers
Williams Patrick F.
Officer: Chief Financial Officer
$916K
Fischer Frank M
Director
$24K
Kumar Rakhi
Director
$15K
Geiger Uri
Director
$12K
Lacob Joseph
Director
$11K
Top Sellers
Morrell Martha
Officer: Chief Medical Officer
$441K
Becker Joel
Director, Officer: Chief Executive Officer
$10K
Insider Activity Analysis
Net Insider Sentiment
Positive insider sentiment with $526K net buying. Buying activity substantially exceeds selling, indicating insider confidence.
Buy/Sell Ratio
Strong buy/sell ratio. Buying is at least double the selling activity, suggesting robust insider confidence.
Insider Participation
5 insider buyers vs. 2 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
NPCE - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 21, 2026 | June 05, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 22, 2025 | June 06, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 22, 2024 | June 07, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 25, 2023 | June 07, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 22, 2022 | June 13, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.